Published in Exp Neurol on July 01, 1995
Cellular responses to psychomotor stimulant and neuroleptic drugs are abnormal in mice lacking the D1 dopamine receptor. Proc Natl Acad Sci U S A (1996) 1.09
Dopamine dynamics and cocaine sensitivity differ between striosome and matrix compartments of the striatum. Neuropharmacology (2016) 0.81
Aripiprazole for schizophrenia. Systematic review. Br J Psychiatry (2006) 2.88
Functional recovery in parkinsonian monkeys treated with GDNF. Nature (1996) 2.35
Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants. J Neurosci (1997) 2.35
Effect of smoking history on [3H]nicotine binding in human postmortem brain. J Pharmacol Exp Ther (1997) 1.98
Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev (2006) 1.93
Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations. J Neurosci (1998) 1.91
Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia. Neuropsychopharmacology (2000) 1.77
Self-referencing ceramic-based multisite microelectrodes for the detection and elimination of interferences from the measurement of L-glutamate and other analytes. Anal Chem (2001) 1.63
Does an encouraging letter encourage attendance at psychiatric out-patient clinics? The Leeds PROMPTS randomized study. Psychol Med (2007) 1.58
Delayed implantation in the spayed, progesterone treated adult mouse. J Reprod Fertil (1966) 1.57
Microelectrode array studies of basal and potassium-evoked release of L-glutamate in the anesthetized rat brain. J Neurochem (2006) 1.56
Systematic does not necessarily mean comprehensive. Br J Psychiatry (1998) 1.54
Student and supervisor perceptions of the quality of supervision in athletic training education. J Athl Train (1997) 1.46
Ceramic-based multisite microelectrodes for electrochemical recordings. Anal Chem (2000) 1.45
Neurobiological studies of sensory gating in schizophrenia. Schizophr Bull (1987) 1.44
Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum. J Neurochem (1999) 1.43
Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level. J Neurosci (1999) 1.42
Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats. Brain Res (1993) 1.40
Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci Lett (1994) 1.40
Effects of the selective adenosine A2 receptor agonist CGS 21680 on in vitro electrophysiology, cAMP formation and dopamine release in rat hippocampus and striatum. J Pharmacol Exp Ther (1990) 1.37
Haloperidol versus placebo for schizophrenia. Cochrane Database Syst Rev (2006) 1.35
Electroconvulsive therapy for schizophrenia. Cochrane Database Syst Rev (2002) 1.34
Nafion-coated electrodes with high selectivity for CNS electrochemistry. Brain Res (1984) 1.34
Regulation of microautophagy and basal protein turnover in rat liver. Effects of short-term starvation. J Biol Chem (1988) 1.34
Critical decline in fine motor hand movements in human aging. Neurology (1999) 1.32
Brain pH has a significant impact on human postmortem hippocampal gene expression profiles. Brain Res (2006) 1.31
Non-commercial clinical trials of a medicinal product: can they survive the current process of research approvals in the UK? J Med Ethics (2006) 1.30
Maintenance of late-phase LTP is accompanied by PKA-dependent increase in AMPA receptor synthesis. Nature (1998) 1.29
Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo. Brain Res Bull (1995) 1.29
In vivo dopamine clearance rate in rat striatum: regulation by extracellular dopamine concentration and dopamine transporter inhibitors. J Pharmacol Exp Ther (1999) 1.26
Second-by-second measures of L-glutamate in the prefrontal cortex and striatum of freely moving mice. J Pharmacol Exp Ther (2007) 1.26
Functional MRI of apomorphine activation of the basal ganglia in awake rhesus monkeys. Brain Res (2000) 1.25
o-Phenylenediamine-modified carbon fiber electrodes for the detection of nitric oxide. Anal Chem (1996) 1.24
Electroconvulsive therapy for schizophrenia. Cochrane Database Syst Rev (2005) 1.22
Pharmacological interventions for people with borderline personality disorder. Cochrane Database Syst Rev (2006) 1.21
Regional effects of aging on dopaminergic function in the Fischer-344 rat. Neurobiol Aging (1992) 1.19
Direct in vivo evidence that D2 dopamine receptors can modulate dopamine uptake. Neurosci Lett (1994) 1.19
Differences in dopamine clearance and diffusion in rat striatum and nucleus accumbens following systemic cocaine administration. J Neurochem (1992) 1.18
The use of 14C-labeled tissue paste standards for the calibration of 125I-labeled ligands in quantitative autoradiography. Neurosci Lett (1987) 1.17
Differential modulation of gene expression in the NMDA postsynaptic density of schizophrenic and control smokers. Brain Res Mol Brain Res (2005) 1.17
Structural differences between insulin receptors in the brain and peripheral target tissues. J Biol Chem (1983) 1.17
The alpha7-nicotinic acetylcholine receptor and the pathology of hippocampal interneurons in schizophrenia. J Chem Neuroanat (2000) 1.14
Randomized controlled trials in Archives of General Psychiatry (1959-1995): a prevalence study. Arch Gen Psychiatry (1998) 1.13
Activation of protein kinase C inhibits uptake, currents and binding associated with the human dopamine transporter expressed in Xenopus oocytes. J Pharmacol Exp Ther (1997) 1.11
Effect of guanine nucleotides on striatal dopamine receptors. Nature (1978) 1.09
Real time in vivo measures of L-glutamate in the rat central nervous system using ceramic-based multisite microelectrode arrays. Ann N Y Acad Sci (2003) 1.09
Forensic trials inform the present and future. Br J Psychiatry (2000) 1.08
Clearance of exogenous dopamine in rat dorsal striatum and nucleus accumbens: role of metabolism and effects of locally applied uptake inhibitors. J Neurochem (1993) 1.08
Functional effects of GDNF in normal rat striatum: presynaptic studies using in vivo electrochemistry and microdialysis. J Pharmacol Exp Ther (1996) 1.07
Age-related changes in the dynamics of potassium-evoked L-glutamate release in the striatum of Fischer 344 rats. J Neural Transm (Vienna) (2004) 1.06
Normal and drug-induced locomotor behavior in aging: comparison to evoked DA release and tissue content in fischer 344 rats. Brain Res (1998) 1.06
Rapid regulation of dopamine transporters by tyrosine kinases in rat neuronal preparations. J Neurochem (2007) 1.06
Inhibitory neurophysiological deficit as a phenotype for genetic investigation of schizophrenia. Am J Med Genet (2000) 1.05
Crisis intervention for people with severe mental illnesses. Cochrane Database Syst Rev (2004) 1.04
The effects of delta 9-tetrahydrocannabinol on potassium-evoked release of dopamine in the rat caudate nucleus: an in vivo electrochemical and in vivo microdialysis study. Brain Res (1988) 1.03
Bilateral 6-OHDA lesions of the locus coeruleus impair associative olfactory learning in newborn rats. Brain Res (1994) 1.03
Multiple single-unit recordings in the striatum of freely moving animals: effects of apomorphine and D-amphetamine in normal and unilateral 6-hydroxydopamine-lesioned rats. Brain Res (1999) 1.02
Crisis intervention for people with severe mental illnesses. Cochrane Database Syst Rev (2006) 1.02
Behavioral and neurochemical effects of intranigral administration of glial cell line-derived neurotrophic factor on aged Fischer 344 rats. J Pharmacol Exp Ther (1997) 1.02
Psychological interventions for those who have sexually offended or are at risk of offending. Cochrane Database Syst Rev (2004) 1.02
Opioid receptor subtype expression defines morphologically distinct classes of hippocampal interneurons. J Neurosci (1999) 1.00
Population genetic structure of Arctic charr, Salvelinus alpinus from northwest Europe on large and small spatial scales. Mol Ecol (2004) 1.00
5-HT(1B) receptor-mediated regulation of serotonin clearance in rat hippocampus in vivo. J Neurochem (2000) 1.00
Fabrication and characterization of sputtered-carbon microelectrode arrays. Anal Chem (1996) 1.00
Persistence of neurochemical changes in dopamine systems after repeated cocaine administration. J Pharmacol Exp Ther (1990) 0.99
Adenosine A2a receptor modulation of electrically evoked endogenous GABA release from slices of rat globus pallidus. J Neurochem (1993) 0.99
In vivo assessment of dopamine uptake in rat medial prefrontal cortex: comparison with dorsal striatum and nucleus accumbens. J Neurochem (1995) 0.99
Protein tyrosine kinase inhibitors alter human dopamine transporter activity in Xenopus oocytes. J Pharmacol Exp Ther (2001) 0.98
Dopamine D2 receptor regulation of the dopamine transporter expressed in Xenopus laevis oocytes is voltage-independent. Mol Pharmacol (2001) 0.98
Sensory physiology and catecholamines in schizophrenia and mania. Psychiatry Res (1990) 0.98
An automated movement assessment panel for upper limb motor functions in rhesus monkeys and humans. J Neurosci Methods (1999) 0.98
Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons. J Comp Neurol (1995) 0.97
Reduced clearance of exogenous dopamine in rat nucleus accumbens, but not in dorsal striatum, following cocaine challenge in rats withdrawn from repeated cocaine administration. J Neurochem (1993) 0.96
Glial cell line-derived neurotrophic factor improves survival of ventral mesencephalic grafts to the 6-hydroxydopamine lesioned striatum. Exp Brain Res (1997) 0.96
Intraputamenal infusion of exogenous neurturin protein restores motor and dopaminergic function in the globus pallidus of MPTP-lesioned rhesus monkeys. Cell Transplant (2008) 0.95
Androgen receptor phosphorylation at serine 515 by Cdk1 predicts biochemical relapse in prostate cancer patients. Br J Cancer (2012) 0.95
Age-related decline in striatal dopamine release and motoric function in brown Norway/Fischer 344 hybrid rats. Brain Res (1998) 0.95
Functional uncoupling of adenosine A(2A) receptors and reduced responseto caffeine in mice lacking dopamine D2 receptors. J Neurosci (2000) 0.94
Diffusion coefficients of neurotransmitters and their metabolites in brain extracellular fluid space. Neuroscience (1985) 0.94
Crisis intervention for people with severe mental illnesses. Cochrane Database Syst Rev (2000) 0.93
Haloperidol versus placebo for schizophrenia. Cochrane Database Syst Rev (2001) 0.92
In vivo electrochemical studies of dopamine clearance in the rat substantia nigra: effects of locally applied uptake inhibitors and unilateral 6-hydroxydopamine lesions. J Neurochem (1998) 0.92
In vivo chronoamperometric measures of extracellular serotonin clearance in rat dorsal hippocampus: contribution of serotonin and norepinephrine transporters. J Pharmacol Exp Ther (1998) 0.91
Dopamine transporter activity in the substantia nigra and striatum assessed by high-speed chronoamperometric recordings in brain slices. J Pharmacol Exp Ther (1998) 0.91
Zinc absorption in anorexia nervosa. Lancet (1985) 0.91
Ethanol potentiates the function of the human dopamine transporter expressed in Xenopus oocytes. J Neurochem (2001) 0.91
Robust modulation of [3H]dopamine release from rat striatal slices by D-2 dopamine receptors. J Pharmacol Exp Ther (1986) 0.91
Insulin resistance impairs nigrostriatal dopamine function. Exp Neurol (2011) 0.91
Methodology for coupling local application of dopamine and other chemicals with rapid in vivo electrochemical recordings in freely-moving rats. J Neurosci Methods (1999) 0.90
Release of monoamines from striatum of rat and mouse evoked by local application of potassium: evaluation of a new in vivo electrochemical technique. J Neurochem (1986) 0.90
Chlorpromazine versus placebo for schizophrenia. Cochrane Database Syst Rev (2003) 0.89
Schizophrenia trials in China: a survey. Acta Psychiatr Scand (2007) 0.89
Dopamine, acting through D-2 receptors, inhibits rat striatal adenylate cyclase by a GTP-dependent process. Mol Pharmacol (1986) 0.88